(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.31%) $78.14
(0.27%) $2.21
(0.00%) $2 324.30
(0.13%) $27.58
(-0.05%) $987.90
(0.17%) $0.931
(0.42%) $10.94
(0.18%) $0.801
(0.00%) $91.44
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 11.45%
@ $1.540
Issued: 14 Feb 2024 @ 11:12
Return: -9.09%
Previous signal: Feb 14 - 09:30
Previous signal:
Return: -1.28 %
Live Chart Being Loaded With Signals
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases...
Stats | |
---|---|
Today's Volume | 4.05M |
Average Volume | 5.03M |
Market Cap | 293.43M |
EPS | $0 ( 2024-03-14 ) |
Next earnings date | ( $-0.0900 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.00 |
ATR14 | $0.00900 (0.64%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-29 | Dahan Michel | Sell | 8 661 | Common Stock |
2024-02-29 | Hadas Nicole R. | Sell | 5 974 | Common Stock |
2024-02-29 | Butler John P. | Sell | 46 570 | Common Stock |
2024-02-29 | Burke Steven Keith | Sell | 7 169 | Common Stock |
2024-02-27 | Hadas Nicole R. | Sell | 7 411 | Common Stock |
INSIDER POWER |
---|
87.62 |
Last 97 transactions |
Buy: 11 050 463 | Sell: 761 907 |
Volume Correlation
Akebia Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
BNIXU | 0.912 |
AMRB | 0.905 |
NIU | 0.904 |
COFS | 0.903 |
WMG | 0.902 |
APWC | 0.895 |
PFG | 0.891 |
QNRX | 0.89 |
ADPT | 0.888 |
CARE | 0.886 |
10 Most Negative Correlations | |
---|---|
RMRM | -0.898 |
LNSR | -0.863 |
DWSH | -0.863 |
GOODM | -0.856 |
HAPP | -0.849 |
XLRN | -0.848 |
GXII | -0.847 |
PLMR | -0.846 |
RCMT | -0.846 |
LHDX | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Akebia Therapeutics Inc Correlation - Currency/Commodity
Akebia Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $194.62M |
Gross Profit: | $118.89M (61.09 %) |
EPS: | $-0.280 |
FY | 2023 |
Revenue: | $194.62M |
Gross Profit: | $118.89M (61.09 %) |
EPS: | $-0.280 |
FY | 2022 |
Revenue: | $292.60M |
Gross Profit: | $207.81M (71.02 %) |
EPS: | $-0.580 |
FY | 2021 |
Revenue: | $213.58M |
Gross Profit: | $60.18M (28.18 %) |
EPS: | $-1.700 |
Financial Reports:
No articles found.
Akebia Therapeutics Inc
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators